Based on these observations, we speculate that HIF-1 inhibition first activates the Cyclin E/Cyclin A pathway, causing S-phase arrest, then it triggers caspases activation, eventually leading to apoptotic cell death after prolonged exposure, supporting the view that HIF-1α inhibition may be an attractive therapeutic strategy for MM. The gene discussed is CCNA2; the disease is Miyoshi myopathy.